Atlas Trials

Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in ICU Patients With Acute Kidney Injury

Clinical trial NCT02042599 · UNKNOWN

Trial details

NCT number
NCT02042599
Sponsor
University Hospital, Clermont-Ferrand
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Kidney Injury
Start date
2014-01-01
Primary completion
2016-02-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.